Health TrialsbyHealthPanel

Moderate to Severe Psoriatic Arthritis

1

Review clinical trials related to Moderate to Severe Psoriatic Arthritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

The purpose of this Phase 2a/b study is: 1. to evaluate the efficacy, safety and tolerability of DDY391 in participants with psoriatic arthritis (PsA). 2. to determine the dose-response relationship of DDY391 in participants with PsA to support dose selection for Phase 3.

Participants needed: 220
Trial details
Phase: Phase 2Age: 18-100Biological sex: AllType: InterventionalSponsor: Novartis PharmaceuticalsUpdated: Oct 13, 2026Locations: 3
Eligibility criteria

Female or male participants at least 18 years of age. [+2]

Presence of inflammatory conditions other than psoriasis or PsA including but no... [+5]

Read more